ClinicalTrials.gg
CompletedNCT06924242Updated Apr 11, 2025

Thyroid Cancer in Surgical Treated Multinodular Goiter

An observational study in Goiter, Nodular, Total Thyroidectomy and Thyroid Cancer, sponsored by University of Foggia. Completed at 1 site in Italy. Per ClinicalTrials.gov, last updated 2025-04-11.

Sponsored by University of Foggia · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
223
Sex
All
01

Study summary

This study aims to investigate, based on existing knowledge, the incidence of occult thyroid carcinoma in a cohort of patients with MNG, providing new insights into the prevalence and characteristics of thyroid malignancies in MNG. It seeks to contribute to optimizing diagnostic evaluations for patients with multinodular goiter.

Read the detailed description

This retrospective study included patients with a preoperative diagnosis of multinodular goiter who underwent total or partial thyroidectomy from January 2018 to May 2024 at the Department of Medical and Surgical Sciences at the University Hospital "Ospedali Riuniti" in Foggia. The study's objective was to investigate the incidence of thyroid carcinoma in patients undergoing thyroidectomy for MNG, also analyzing associated demographic and clinical variables.

02

Conditions studied

  • Goiter, Nodular
  • Total Thyroidectomy
  • Thyroid Cancer
03

In context

Goiter, Nodular

19 studies on the registry are indexed under Goiter, Nodular; 6 are open to participants now.

Browse Goiter, Nodular studies →

Lead sponsor

University of Foggia is the lead sponsor of 36 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients of both sex with cancer incidence in multinodular thyroid goiter who underwent surgery in the same center

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients diagnosed with multinodular goiter via thyroid ultrasound, with or without FNA cytology.
  • patients who underwent surgery.
  • availability of complete clinical data

Exclusion criteria

Exclusion Criteria:

  • history of thyroid carcinoma or other thyroid neoplasms.
  • not completed postoperative follow up.
  • patients with preoperative FNA results indicating (TIR 4-5), suspicion of malignancy (TIR 3), or indeterminate significance (TIR 1)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
223 participants (actual)
Patient registry
No

Groups and cohorts

  • Patient with multinodular goiter who underwent total or partial thyroidectomy

    Procedure: total or partial thyroidectomy

Interventions

  • Proceduretotal or partial thyroidectomy

    Total thyroidectomy is a surgical procedure that involves the complete removal of the thyroid gland. It is performed to treat conditions such as thyroid cancer, large goiters, or severe hyperthyroidism. The surgery is typically conducted under general anesthesia through an incision in the lower neck. Postoperative management may include hormone replacement therapy with levothyroxine to compensate for the loss of thyroid function. Potential complications include hypocalcemia due to parathyroid gland injury and vocal cord dysfunction from recurrent laryngeal nerve damage.

06

What researchers measure

Primary outcomes

  1. incidence of occult thyroid carcinoma

    Incidence of occult thyroid carcinoma in a cohort of patients with multinodular goiter, providing new insights into the prevalence and characteristics of thyroid malignancies.

    Time frame: 6 years

07

Study locations

1 site
  • University of Foggia
    Foggia, FG 71122, Italy
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06924242
Lead sponsor
University of Foggia
Responsible party
Giovanna Pavone (Medical Doctor, University of Foggia) — Principal investigator
First posted
Apr 11, 2025
Start date
Jan 1, 2018
Primary completion
May 30, 2024
Completion
Jul 31, 2024
Last update
Apr 11, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion